Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2023 · 10-Q
Revenue$674.10M$674.10M+8.6% vs Q3 2022 Net Income-$4.90M-$4.90MN/M vs Q3 2022 EPS Diluted-$0.04-$0.04N/M vs Q3 2022 Operating Income$82,600,000+11.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$85,700,000+591.1% Margins · derivedOperating margin12.3%+0.3 pt vs Q3 2022
Net margin-0.7%+3.3 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 7, 2023 · 38 d after period end